The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.
Heimberger
Amy B
AB
Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Kong
Ling-Yuan
LY
Abou-Ghazal
Mohamed
M
Reina-Ortiz
Chantal
C
Yang
David S
DS
Wei
Jun
J
Qiao
Wei
W
Schmittling
Robert J
RJ
Archer
Gary E
GE
Sampson
John H
JH
Hiraoka
Nobuyoshi
N
Priebe
Waldemar
W
Fuller
Gregory N
GN
Sawaya
Raymond
R
D000818:Animals; D001932:Brain Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D018929:Cell Culture Techniques; D015331:Cohort Studies; D004195:Disease Models, Animal; D005260:Female; D051858:Forkhead Transcription Factors; D005910:Glioma / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D011725:Pyridines / Q000494:pharmacology*; D012189:Retrospective Studies; D050796:STAT3 Transcription Factor / Q000037:antagonists & inhibitors; D015996:Survival Rate; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects* / Q000502:physiology; D020032:Tyrphostins / Q000494:pharmacology*
C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; D011725:Pyridines; D050796:STAT3 Transcription Factor; D020032:Tyrphostins; C519885:WP1066